Advertisement
Screener

CORE LABORATORIES N.V. Form 8-K: Current report, 2010

CORE LABORATORIES N.V. Form 8-K: Current report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2010-12-20: Form 8-K; Period of report 2010-12-20; Description 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Details 1.01.
  • 2010-10-22: Form 8-K; Period of report 2010-10-21; Description 7.01 Regulation FD Disclosure; Details 7.01.
  • 2010-10-20: Form 8-K; Period of report 2010-10-20; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
  • 2010-10-20: Form 8-K; Period of report 2010-10-20; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
FiledFormPeriod of reportDescriptionDetailsDocument
2010-12-208-K2010-12-201.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant1.01 On December 17, 2010, Core Laboratories N.V. and Core Laboratories LP amended its current credit agreement and entered into the Fifth Amended and Restated Credit Agreement (henceforth referred to as the “Amended Credit Agreement”) with various financial institutions which are or may become parties to the Amended Credit Agreement (collectively, the “Lenders”), Bank of America, N.A. as administrative agent for the Lenders and as a letter of credit issuing bank.
2.03 The information set forth under Item 1.01 above is incorporated herein by reference.
clb-8k_creditagreement.htm
2010-10-228-K2010-10-217.01 Regulation FD Disclosure7.01 As a result of our dividend payable to shareholders of record as of October 22, 2010, the exchange rate on our Senior Exchangeable Notes (the “Notes”) has been adjusted to 21.8578 per $1,000 principal amount of the outstanding Notes.clb-8k_exchange.htm
2010-10-208-K2010-10-202.02 Results of Operations and Financial Condition2.02 On October 20, 2010, Core Laboratories N.V. issued a press release announcing its financial results for the third quarter of 2010 and year-to-date as of September 30, 2010.clb-8k_earningsrelease.htm
2010-10-208-K2010-10-202.02 Results of Operations and Financial Condition2.02 On October 20, 2010, Core Laboratories N.V. issued a press release announcing its financial results for the third quarter of 2010 and year-to-date as of September 30, 2010.clb-8k_earningsrelease.htm
2010-10-208-K2010-10-202.02 Results of Operations and Financial Condition2.02 On October 20, 2010, Core Laboratories N.V. issued a press release announcing its financial results for the third quarter of 2010 and year-to-date as of September 30, 2010.clb-8k_earningsrelease.htm
2010-10-128-K2010-10-127.01 Regulation FD Disclosure7.01 On October 12, 2010, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.06 per share of common stock for shareholders of record on October 22, 2010 and payable November 24, 2010.clb-8k_dividend.htm
2010-07-218-K2010-06-302.02 Results of Operations and Financial Condition2.02 On July 21, 2010, Core Laboratories N.V. issued a press release announcing its financial results for the second quarter of 2010 and year-to-date as of June 30, 2010.clb-8k_earningsrelease.htm
2010-07-128-K2010-07-127.01 Regulation FD Disclosure7.01 On July 12, 2010, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.06 per share of common stock and a one-time special cash dividend of $0.65 per share of common stock for shareholders of record on July 23, 2010 and payable August 23, 2010.clb-8k_dividend.htm
2010-06-148-K2010-06-105.07 Submission of Matters to a Vote of Security Holders; 7.01 Regulation FD Disclosure5.07 Core Laboratories N.V. (the “Company”) held its Annual Meeting of Shareholders (the “Annual Meeting”) on June 10, 2010.
7.01 On June 14, 2010, the Company issued a press release announcing that the Company’s shareholders approved the Supervisory Board’s proposal at the Annual Meeting of Shareholders held on June 10, 2010 for a two-for-one stock split of its common stock.
h73819e8vk.htm
2010-04-288-K2010-03-312.02 Results of Operations and Financial Condition2.02 On April 28, 2010, Core Laboratories N.V. issued a press release announcing its financial results for the first quarter of 2010.clb-8k_earningsrelease.htm
2010-04-168-K2010-04-167.01 Regulation FD Disclosure7.01 On April 16, 2010, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend equal to $0.12 per share of common stock for shareholders of record on April 27, 2010 and payable May 27, 2010.clb-8k_dividend.htm
2010-04-158-K2010-04-152.02 Results of Operations and Financial Condition2.02 On April 15, 2010 Core Laboratories N.V. issued a press release announcing revisions to previously issued earnings guidance for its 2010 first fiscal quarter and fiscal year 2010.clk-8k_earnings.htm
2010-02-108-K2009-12-312.02 Results of Operations and Financial Condition2.02 On February 10, 2010, Core Laboratories N.V. issued a press release announcing its financial results for the fourth quarter of 2009 and full year December 31, 2009.clb-8k_earningsrelease.htm
2010-01-148-K2010-01-147.01 Regulation FD Disclosure7.01 On January 14, 2010, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend equal to $0.12 per share of common stock for shareholders of record on January 25, 2010 and payable February 25, 2010.clb-8k_dividend.htm